Balanced news tone
News Sentiment
ABVX sentiment intelligence
ABIVAX Société Anonyme news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-9.9% over one week, +43.9% over four weeks, trend inactive, and near fair-value range.
Brummer Multi Strategy AB Boosts Position in Abivax SA Sponsored ADR $ABVX
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Brummer Multi Strategy AB Boosts Position in Abivax SA Sponsored ADR $ABVX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 08:56
- Source
- MarketBeat
Abivax: Obefazimod Goes The Distance And So Does My Buy Rating (NASDAQ:ABVX)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 16 Jul 2026 14:25
- Source
- Seeking Alpha
Diversify Wealth Management LLC Purchases 14,626 Shares of Abivax SA Sponsored ADR $ABVX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 07:52
- Source
- MarketBeat
Candriam S.C.A. Takes $4.01 Million Position in Abivax SA Sponsored ADR $ABVX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 07:50
- Source
- MarketBeat
Abivax: Wall Street Catches Up to the Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 07:00
- Source
- Market source
Is ABIVAX Société Anonyme (ABVX) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Market source
ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Abivax raises $800M as dilution hits 8% and cash reaches 2029
- Tone
- Positive 66/100
- Event
- Balance sheet
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
ABIVAX (ENXTPA:ABVX) Stock Looks Expensive Even After Strong Trial Progress
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Market source
Stocks making the biggest moves midday: AeroVironment, Abivax, Astera Labs, Watts Water Technologies & more
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- CNBC
Abivax rebounds from stock drop with safety data for much-hyped colitis prospect
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Fierce Biotech
ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Stocktwits
Abivax (ABVX) Jumps 16% on Bargain-Hunting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Market source
Abivax Shares Tumble Despite Strong Ulcerative Colitis Trial Results as Safety Concerns Emerge (ABVX)
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 02 Jun 2026 07:00
- Source
- Market source
What Makes Abivax SA Sponsored ADR (ABVX) a Strong Momentum Stock: Buy Now?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Market source
ABIVAX Société Anonyme (ENXTPA:ABVX) Is Up 6.9% After Long-Term Obefazimod Data And Q1 Results - Has The Bull Case Changed?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 May 2026 07:00
- Source
- Market source
Assessing ABIVAX Société Anonyme (ENXTPA:ABVX) Valuation After Recent Share Price Softness And Conflicting Metrics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Market source